OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Publication Date
Release Date
2017
(4)
2022
(3)
2019
(3)
2020
(2)
2015
(2)
2011
(2)
2026
(1)
2023
(1)
2018
(1)
2016
(1)
2014
(1)
2013
(1)
2010
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697).
Not available
S-EPMC5455684
|
biostudies-literature
Cite
Talimogene laherparepvec for regionally advanced Merkel cell carcinoma: A report of 2 cases.
Not available
S-EPMC5394182
|
biostudies-literature
Cite
Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy: systematic review and meta-analysis.
Not available
S-EPMC9119900
|
biostudies-literature
Cite
Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years.
Not available
S-EPMC4303987
|
biostudies-literature
Cite
Observational study of talimogene laherparepvec use for melanoma in clinical practice in the United States (COSMUS-1).
Not available
S-EPMC6688558
|
biostudies-literature
Cite
Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis.
Not available
S-EPMC3758382
|
biostudies-literature
Cite
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial.
Not available
S-EPMC8063889
|
biostudies-literature
Cite
Pimasertib Versus Dacarbazine in Patients With Unresectable
NRAS
-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover.
Not available
S-EPMC7408351
|
biostudies-literature
Cite
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naive patients with metastatic melanoma.
Not available
S-EPMC6279094
|
biostudies-literature
Cite
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies.
Not available
S-EPMC8258671
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets